GO
Loading...

Enter multiple symbols separated by commas

Mylan Inc

More

  • Teva discloses 1.35 pct stake in target Mylan Wednesday, 27 May 2015 | 4:42 PM ET

    May 27- Teva Pharmaceutical Industries Ltd disclosed a 1.35 percent interest in Mylan NV, saying the purchase underscored its commitment to buy Mylan as soon as possible. Teva proposed to buy Mylan for $82 per share, or about $43 billion, in cash and stock last month. Mylan rejected the offer saying it "grossly undervalued" the company, setting up a three-way battle...

  • TRENTON, N.J.— Drugmaker Endo International PLC is climbing toward the top of the steadily consolidating generic medicine business with a deal to buy Par Pharmaceutical Holdings Inc. for about $8.05 billion. In the U.S., that includes the biggest health insurers and two pharmacy benefit managers, Express Scripts Holding Co. and CVS Health Corp. In other...

  • The company has been steadfast in its refusal to combine with Teva and is instead encouraging shareholders to support its own $34 billion unsolicited offer for over-the-counter drugmaker Perrigo Co Plc. Teva said on Tuesday it will move ahead with its plans to acquire Mylan if the Perrigo deal is not completed. Speaking privately to investors this week,...

  • Early movers: GEVA, MGI, JPM, WEN, NWSA & more Wednesday, 6 May 2015 | 7:51 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • May 5- Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, said on Tuesday it is fully committed to acquiring Ireland- based Perrigo Co and believes it can complete the deal by year end. Mylan, on a conference call with analysts, said it is legally committed to take its offer directly to Perrigo shareholders under Irish takeover...

  • After-hours buzz: Herbalife, EA, Zulily & more Tuesday, 5 May 2015 | 5:32 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Check out the companies making headlines after the bell Tuesday: Herbalife, EA, Zulily & more.

  • May 5- Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, said on Tuesday it is fully committed to acquiring Ireland- based Perrigo Co.. "We remain steadfast in our legally binding commitment to acquire Perrigo and have taken numerous concrete steps to lay out a clear and certain path towards completion," Mylan Chief Executive...

  • May 5- Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, on Tuesday reported slightly higher-than-expected first-quarter profit and said it was "steadfast" in its commitment to acquire Ireland- based Perrigo Co.. Perrigo last week rejected a sweetened $34 billion offer from Mylan. At the same time, Mylan is attempting to fend...

  • What matters to markets this week Monday, 4 May 2015 | 6:00 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE)

    Influences from abroad may first drive stocks, bonds and the dollar.

  • Jobs report is big but watch out for Europe Friday, 1 May 2015 | 7:21 PM ET
    Traders work on the floor of the New York Stock Exchange (NYSE)

    Influences from abroad may first drive stocks, bonds and the dollar.

  • Biotech bust may be sending message about stocks Thursday, 30 Apr 2015 | 5:03 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Traders are watching the iShares Nasdaq Biotechnology ETF for clues on whether a deeper stock market decline is on the horizon.

  • Surprise! Women trump men on CEO pay Thursday, 30 Apr 2015 | 10:31 AM ET
    Marissa Mayer, president and chief executive officer at Yahoo! Inc.

    Female CEO pay, on average, outstrips pay to all the male CEOs of the 100 largest publicly held companies reports USA Today.

  • *Q1 adjusted EPS $1.36 vs $1.25 forecast. *Raises 2015 adjusted EPS forecast to $5.05- $5.35. TEL AVIV, April 30- Teva Pharmaceutical Industries raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion- plus bid for rival Mylan Inc..

  • *Q1 adjusted EPS $1.36 vs $1.25 forecast. *Raises 2015 adjusted EPS forecast to $5.05- $5.35. TEL AVIV, April 30- Teva Pharmaceutical Industries, which is seeking to acquire rival Mylan Inc for over $40 billion, raised its full-year earnings outlook after posting a bigger-than-expected increase in first-quarter profit.

  • Faber: Perrigo to reject latest Mylan offer   Wednesday, 29 Apr 2015 | 10:42 AM ET
    Faber: Perrigo to reject latest Mylan offer

    CNBC's David Faber reports Perrigo will reject Mylan's latest offer.

  • Mylan sweetens bid for Perrigo Wednesday, 29 Apr 2015 | 10:38 AM ET
    Perrigo facility in Allegan, Michigan

    Mylan on Wednesday sweetened its bid for Perrigo.

  • Mylan raises bid for Perrigo   Wednesday, 29 Apr 2015 | 9:20 AM ET
    Mylan raises bid for Perrigo

    CNBC's David Faber reports Mylan is increasing its bid for Mylan.

  • US markets waver ahead of Fed meeting Monday, 27 Apr 2015 | 6:52 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Investors proved cautious ahead of the Federal Reserve's two-day policy meeting that ends on Wednesday.

  • Your first trade for Tuesday Monday, 27 Apr 2015 | 6:38 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Biotechs stick it to stocks Monday, 27 Apr 2015 | 4:30 PM ET
    Medical injection

    Biotech is getting roughed up, after leading the market's gains this year.